Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.
Identifieur interne : 000738 ( Main/Merge ); précédent : 000737; suivant : 000739Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.
Auteurs : Patrick Rossignol [France] ; Faiez Zannad [France]Source :
- Circulation [ 1524-4539 ] ; 2015.
Descripteurs français
- KwdFr :
- Antagonistes des récepteurs des minéralocorticoïdes (usage thérapeutique), Benzimidazoles (usage thérapeutique), Débit systolique (physiologie), Défaillance cardiaque (physiopathologie), Défaillance cardiaque (traitement médicamenteux), Dérivés du biphényle (usage thérapeutique), Femelle, Fluorobenzènes (usage thérapeutique), Géographie, Humains, Internationalité, Mâle, Patients, Pyrimidines (usage thérapeutique), Rosuvastatine de calcium, Spironolactone (usage thérapeutique), Sulfonamides (usage thérapeutique), Tétrazoles (usage thérapeutique).
- MESH :
- physiologie : Débit systolique.
- physiopathologie : Défaillance cardiaque.
- traitement médicamenteux : Défaillance cardiaque.
- usage thérapeutique : Antagonistes des récepteurs des minéralocorticoïdes, Benzimidazoles, Dérivés du biphényle, Fluorobenzènes, Pyrimidines, Spironolactone, Sulfonamides, Tétrazoles.
- Femelle, Géographie, Humains, Internationalité, Mâle, Patients, Rosuvastatine de calcium.
English descriptors
- KwdEn :
- Benzimidazoles (therapeutic use), Biphenyl Compounds (therapeutic use), Female, Fluorobenzenes (therapeutic use), Geography, Heart Failure (drug therapy), Heart Failure (physiopathology), Humans, Internationality, Male, Mineralocorticoid Receptor Antagonists (therapeutic use), Patients, Pyrimidines (therapeutic use), Rosuvastatin Calcium, Spironolactone (therapeutic use), Stroke Volume (physiology), Sulfonamides (therapeutic use), Tetrazoles (therapeutic use).
- MESH :
- chemical , therapeutic use : Benzimidazoles, Biphenyl Compounds, Fluorobenzenes, Mineralocorticoid Receptor Antagonists, Pyrimidines, Spironolactone, Sulfonamides, Tetrazoles.
- drug therapy : Heart Failure.
- physiology : Stroke Volume.
- physiopathology : Heart Failure.
- Female, Geography, Humans, Internationality, Male, Patients, Rosuvastatin Calcium.
DOI: 10.1161/CIRCULATIONAHA.114.013637
PubMed: 25406307
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000064
- to stream PubMed, to step Curation: 000064
- to stream PubMed, to step Checkpoint: 000039
- to stream Ncbi, to step Merge: 000177
- to stream Ncbi, to step Curation: 000171
- to stream Ncbi, to step Checkpoint: 000171
Links to Exploration step
pubmed:25406307Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.</title><author><name sortKey="Rossignol, Patrick" sort="Rossignol, Patrick" uniqKey="Rossignol P" first="Patrick" last="Rossignol">Patrick Rossignol</name><affiliation wicri:level="1"><nlm:affiliation>From Inserm, Centre d'Investigations Cliniques-Plurithématique 1433 and Inserm U1116, Nancy, France (P.R., F.Z.); CHU Nancy, Département de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France (P.R., F.Z.); Université de Lorraine, Nancy, France (P.R., F.Z.); and INI-CRCT (Cardiovascular and Renal Clinical Trialists), French-Clinical Research Infrastructure Network (F-CRIN), Nancy, France (P.R., F.Z.). p.rossignol@chu-nancy.fr.</nlm:affiliation><country wicri:rule="url">France</country></affiliation></author><author><name sortKey="Zannad, Faiez" sort="Zannad, Faiez" uniqKey="Zannad F" first="Faiez" last="Zannad">Faiez Zannad</name><affiliation wicri:level="4"><nlm:affiliation>From Inserm, Centre d'Investigations Cliniques-Plurithématique 1433 and Inserm U1116, Nancy, France (P.R., F.Z.); CHU Nancy, Département de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France (P.R., F.Z.); Université de Lorraine, Nancy, France (P.R., F.Z.); and INI-CRCT (Cardiovascular and Renal Clinical Trialists), French-Clinical Research Infrastructure Network (F-CRIN), Nancy, France (P.R., F.Z.).</nlm:affiliation><orgName type="university">Université de Lorraine</orgName><country>France</country><placeName><settlement type="city">Nancy</settlement><settlement type="city">Metz</settlement><region type="region" nuts="2">Grand Est</region><region type="old region" nuts="2">Lorraine (région)</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25406307</idno><idno type="pmid">25406307</idno><idno type="doi">10.1161/CIRCULATIONAHA.114.013637</idno><idno type="wicri:Area/PubMed/Corpus">000064</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000064</idno><idno type="wicri:Area/PubMed/Curation">000064</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000064</idno><idno type="wicri:Area/PubMed/Checkpoint">000039</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000039</idno><idno type="wicri:Area/Ncbi/Merge">000177</idno><idno type="wicri:Area/Ncbi/Curation">000171</idno><idno type="wicri:Area/Ncbi/Checkpoint">000171</idno><idno type="wicri:Area/Main/Merge">000738</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.</title><author><name sortKey="Rossignol, Patrick" sort="Rossignol, Patrick" uniqKey="Rossignol P" first="Patrick" last="Rossignol">Patrick Rossignol</name><affiliation wicri:level="1"><nlm:affiliation>From Inserm, Centre d'Investigations Cliniques-Plurithématique 1433 and Inserm U1116, Nancy, France (P.R., F.Z.); CHU Nancy, Département de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France (P.R., F.Z.); Université de Lorraine, Nancy, France (P.R., F.Z.); and INI-CRCT (Cardiovascular and Renal Clinical Trialists), French-Clinical Research Infrastructure Network (F-CRIN), Nancy, France (P.R., F.Z.). p.rossignol@chu-nancy.fr.</nlm:affiliation><country wicri:rule="url">France</country></affiliation></author><author><name sortKey="Zannad, Faiez" sort="Zannad, Faiez" uniqKey="Zannad F" first="Faiez" last="Zannad">Faiez Zannad</name><affiliation wicri:level="4"><nlm:affiliation>From Inserm, Centre d'Investigations Cliniques-Plurithématique 1433 and Inserm U1116, Nancy, France (P.R., F.Z.); CHU Nancy, Département de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France (P.R., F.Z.); Université de Lorraine, Nancy, France (P.R., F.Z.); and INI-CRCT (Cardiovascular and Renal Clinical Trialists), French-Clinical Research Infrastructure Network (F-CRIN), Nancy, France (P.R., F.Z.).</nlm:affiliation><orgName type="university">Université de Lorraine</orgName><country>France</country><placeName><settlement type="city">Nancy</settlement><settlement type="city">Metz</settlement><region type="region" nuts="2">Grand Est</region><region type="old region" nuts="2">Lorraine (région)</region></placeName></affiliation></author></analytic><series><title level="j">Circulation</title><idno type="eISSN">1524-4539</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Benzimidazoles (therapeutic use)</term><term>Biphenyl Compounds (therapeutic use)</term><term>Female</term><term>Fluorobenzenes (therapeutic use)</term><term>Geography</term><term>Heart Failure (drug therapy)</term><term>Heart Failure (physiopathology)</term><term>Humans</term><term>Internationality</term><term>Male</term><term>Mineralocorticoid Receptor Antagonists (therapeutic use)</term><term>Patients</term><term>Pyrimidines (therapeutic use)</term><term>Rosuvastatin Calcium</term><term>Spironolactone (therapeutic use)</term><term>Stroke Volume (physiology)</term><term>Sulfonamides (therapeutic use)</term><term>Tetrazoles (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antagonistes des récepteurs des minéralocorticoïdes (usage thérapeutique)</term><term>Benzimidazoles (usage thérapeutique)</term><term>Débit systolique (physiologie)</term><term>Défaillance cardiaque (physiopathologie)</term><term>Défaillance cardiaque (traitement médicamenteux)</term><term>Dérivés du biphényle (usage thérapeutique)</term><term>Femelle</term><term>Fluorobenzènes (usage thérapeutique)</term><term>Géographie</term><term>Humains</term><term>Internationalité</term><term>Mâle</term><term>Patients</term><term>Pyrimidines (usage thérapeutique)</term><term>Rosuvastatine de calcium</term><term>Spironolactone (usage thérapeutique)</term><term>Sulfonamides (usage thérapeutique)</term><term>Tétrazoles (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Benzimidazoles</term><term>Biphenyl Compounds</term><term>Fluorobenzenes</term><term>Mineralocorticoid Receptor Antagonists</term><term>Pyrimidines</term><term>Spironolactone</term><term>Sulfonamides</term><term>Tetrazoles</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Débit systolique</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Stroke Volume</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antagonistes des récepteurs des minéralocorticoïdes</term><term>Benzimidazoles</term><term>Dérivés du biphényle</term><term>Fluorobenzènes</term><term>Pyrimidines</term><term>Spironolactone</term><term>Sulfonamides</term><term>Tétrazoles</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Geography</term><term>Humans</term><term>Internationality</term><term>Male</term><term>Patients</term><term>Rosuvastatin Calcium</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Femelle</term><term>Géographie</term><term>Humains</term><term>Internationalité</term><term>Mâle</term><term>Patients</term><term>Rosuvastatine de calcium</term></keywords></textClass></profileDesc></teiHeader></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/InforLorV4/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000738 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000738 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Lorraine
|area= InforLorV4
|flux= Main
|étape= Merge
|type= RBID
|clé= pubmed:25406307
|texte= Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:25406307" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a InforLorV4
| This area was generated with Dilib version V0.6.33. |  |